60 trends tracked about this subject — the full history, oldest to newest below.
Musician Jelly Roll uses his appearance on Jimmy Kimmel Live! to joke about weight loss and offer blunt health advice to Donald Trump.
Medical experts and researchers are analyzing whether the rise of GLP-1 drugs signals a turning point for obesity rates in the United States.
Producer Benny Blanco has sparked conversation after revealing the weight loss results of a five-day experiment eating only pizza.
Recent reporting examines the expanding medical landscape surrounding GLP-1 weight loss medications.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage highlights a study showing that a low-fat vegan diet helps individuals lose weight without restricting food.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent discussions highlight a shift in the narrative surrounding weight-loss drugs, focusing on gender dynamics and the desire for medical privacy.
New scientific discoveries regarding brain circuits may redefine the understood mechanism of GLP-1 weight loss drugs like Ozempic and Wegovy.
Eli Lilly targets the illicit market for its unapproved obesity drug retatrutide through new legal actions.
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
A new study reveals that a low-fat vegan diet reduces dietary energy density by nearly a third, facilitating weight loss without conscious calorie cutting.
Actor John Goodman is sparking widespread conversation after photos reveal a dramatic weight loss transformation ahead of his return to the big screen.
John Goodman’s startling 90kg (200‑pound) transformation has fans scrambling for the new look of the 74‑year‑old Roseanne star.
Kendra Wilkinson returns to the gym for the first time in two years amid her ongoing GLP-1 weight loss journey.
Bank of America is spending $250 million annually on weight loss drugs for staff, highlighting corporate healthcare trends.
Regulators receive hundreds of reports linking popular weight-loss drugs to deaths.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Amy Schumer shares unfiltered bikini photos from a yacht trip, highlighting her weight loss progress after a year on Mounjaro.
GLP-1 weight loss drugs are trending as usage hits new highs in the US and experts address long-term treatment challenges.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Pharmacists and health experts are urging GLP-1 weight loss medication users to prioritize specific nutritional strategies to mitigate side effects.
Eli Lilly targets a first-quarter 2027 FDA application for its next-generation obesity drug retatrutide.
Eli Lilly is moving toward 2027 regulatory filings for retatrutide after successful Phase 3 obesity trials showing significant weight and A1C improvements.
New research links GLP-1 weight-loss medications like Ozempic and Mounjaro to an increased risk of hair loss in patients.
Social media influencers are promoting the cyclospora parasite as a dangerous rapid weight loss method.
Emerging trends in GLP-1 medications highlight an expansion beyond weight loss, including therapeutic retreats and rising use among young adults.
Rapid adoption of GLP-1 weight-loss drugs is sparking new debates over adolescent use, compounded safety, and the social stigma of medication.
Recent scientific findings indicate that specific intermittent fasting eating windows can help individuals maintain weight loss over a full year.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New health trends highlight the use of resistant starch to transform common carbohydrates into gut-friendly prebiotics for weight loss and microbiota health.
Recent medical reviews suggest users of GLP-1 weight-loss medications may face significant weight regain after stopping treatment.
New research suggests that just 12 weeks of intermittent fasting may help individuals sustain weight loss a full year after the diet ends.
Recent studies examine a low-protein longevity diet linked to healthier aging, fat reduction, and natural GLP-1 boosts in mice.
Medical professionals are warning GLP-1 medication users about 'Ozempic feet,' a surprising new side effect emerging alongside rapid weight loss.
Amy Schumer is drawing attention for sharing photos of her C-section scar and discussing her weight loss journey during July 4th celebrations.
Researchers have identified a protein called 'Mitch' that regulates fat energy consumption, potentially impacting future obesity treatments.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Scientists have identified a protein switch in human cells that dictates whether the body stores or burns fat.
Wegovy weight‑loss pill hits UK shelves today, sparking a predicted rush of tens of thousands of users.
Recent coverage examines the rising prominence of protein, fitness strategies, and dietary guidance across multiple media outlets.
GLP-1 weight‑loss drugs spark a wave of research, clinical guidance and market buzz as they expand beyond obesity treatment.
Research into GLP-1 receptor agonists is shifting focus from weight management to potential longevity benefits and broader therapeutic applications.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent research reveals that individuals using GLP-1 weight-loss medications exhibit a decline in physical activity levels.